Teriflunomide-Induced Palmoplantar Pustular Psoriasis: Case Report and Review of the Literature

Teriflunomide is a once-daily oral immunomodulatory disease-modifying treatment for multiple sclerosis (MS). Skin reactions are an infrequent side effect of teriflunomide. Here, we present the case of a 52-year-old female patient with ankylosing spondylitis who was consulted for demyelinating lesion...

Descripción completa

Detalles Bibliográficos
Autores principales: Demirel Ozbek, Ezgi, Akdogan, Neslihan, Ates Ozdemir, Deniz, Acar Ozen, Nazire Pinar, Tuncer, Aslı
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472710/
https://www.ncbi.nlm.nih.gov/pubmed/37664364
http://dx.doi.org/10.7759/cureus.42845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472710/
https://www.ncbi.nlm.nih.gov/pubmed/37664364
http://dx.doi.org/10.7759/cureus.42845

Ejemplares similares